| Synonyms: | |
| Status: | Approved (2005) |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| ATC: | H01AC03 |
| UNII: | 7GR9I2683O |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Insulin-like growth factor I receptor agonist | DailyMed |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetes Mellitus | 3 | D003920 | ClinicalTrials |
| Amyotrophic Lateral Sclerosis | 3 | D000690 | ClinicalTrials |
| Multiple Sclerosis | 2 | D009103 | ClinicalTrials |
| Noonan Syndrome | 2 | D009634 | ClinicalTrials |
| Crohn Disease | 2 | D003424 | ClinicalTrials |
| Laron Syndrome | 2 | D046150 | ClinicalTrials |
| Rett Syndrome | 2 | D015518 | ClinicalTrials |
| Bone Diseases | 2 | D001847 | ClinicalTrials |
| Hyperinsulinism | 2 | D006946 | ClinicalTrials |
| Retinopathy of Prematurity | 2 | D012178 | ClinicalTrials |
| Anorexia Nervosa | 1 | D000856 | ClinicalTrials |
| HIV-Associated Lipodystrophy Syndrome | 1 | D039682 | ClinicalTrials |
| Tendinopathy | 0 | D052256 | ClinicalTrials |
| Aging | 0 | D000375 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 68562-41-4 |
| ChEMBL | CHEMBL1201716 |
| FDA SRS | 7GR9I2683O |